www.bectastx.com
The company develops monoclonal antibody therapies that enhance immune response against various cancer types by combining antibodies with precision insights from pre-clinical studies. This approach aims to improve treatment efficacy and patient outcomes in oncology.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops monoclonal antibody therapies that enhance immune response against various cancer types by combining antibodies with precision insights from pre-clinical studies. This approach aims to improve treatment efficacy and patient outcomes in oncology.